Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 4;69(6):e0192024.
doi: 10.1128/aac.01920-24. Epub 2025 Apr 22.

Evaluation of shorter versus longer antifungal treatment durations for Candida spp. urinary tract infections among hospitalized adults

Affiliations

Evaluation of shorter versus longer antifungal treatment durations for Candida spp. urinary tract infections among hospitalized adults

Jacob C Govel et al. Antimicrob Agents Chemother. .

Abstract

Infectious Diseases Society of America guidelines recommend 14 days of treatment for Candida spp. urinary tract infections (UTIs). To our knowledge, no data are available to compare <14 days for Candida spp. UTI. This was a single-center, retrospective cohort study between 01 January 2015 and 01 January 2024. Hospitalized adults with >1 urine culture with Candida spp. and symptoms who initiated >1 antifungal dose within 96 hours were included. Multiple exclusion criteria existed, including but not limited to if Candida spp. were isolated from another site, antifungals were received for another indication, or the participant was asymptomatic. The primary outcome was clinical treatment success. Binary logistic regression was performed to further assess the relationship between fluconazole duration and clinical treatment success. Among 2,400 patients with candiduria, 45 and 58 in the 14-day and <14-day cohorts were assessed after exclusion criteria were applied, respectively. Median (interquartile range) fluconazole duration was 14 (14-14) days in the 14-day cohort and 7 (5-7) in the <14-day cohort. There was no difference in clinical treatment success in patients treated for 14 days vs <14 days (14 days: 93.3% (42/45) vs <14 days: 93.1% (54/58), P = 1.000; between-group difference (95% CI: 0.02 [-9.6 to 10]). Fluconazole duration did not have a significant association with clinical treatment success on binary logistic regression (P = 0.503; odds ratio 0.917 [95% CI: 0.712-1.181]). There was no statistically significant difference in clinical treatment success in patients treated with fluconazole for a median of 14 days vs a median of 7 days for symptomatic Candida spp. UTI. These data support the potential utility of shorter antifungal durations for Candida spp. UTI.

Keywords: Candida; antifungal; duration; fluconazole; urinary tract infection.

PubMed Disclaimer

Conflict of interest statement

W.D.K. discloses research funding from Melinta Therapeutics and Merck and Co., consultation honoraria from Shionogi, Inc., and is on an advisory board at Theratechnologies. E.A.A.-R. has received funds from Abbvie, GSK, and Theratechnologies for studies on which she is an investigator. All other authors have nothing to disclose.

Figures

Fig 1
Fig 1
Patient inclusion and exclusion.

References

    1. Kauffman CA. 2014. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am 28:61–74. doi:10.1016/j.idc.2013.09.004 - DOI - PubMed
    1. Sobel JD, Fisher JF, Kauffman CA, Newman CA. 2011. Candida urinary tract infections—epidemiolog. Clin Infect Dis 52:S433–D436. doi:10.1093/cid/cir109 - DOI - PubMed
    1. Kauffman CA, Vazquez JA, Sobel JD, Gallis HA, McKinsey DS, Karchmer AW, Sugar AM, Sharkey PK, Wise GJ, Mangi R, Mosher A, Lee JY, Dismukes WE, National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group . 2000. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30:14–18. doi:10.1086/313583 - DOI - PubMed
    1. Achkar JM, Fries BC. 2010. Candida infections of the genitourinary tract. Clin Microbiol Rev 23:253–273. doi:10.1128/CMR.00076-09 - DOI - PMC - PubMed
    1. Alvarez-Lerma F, Nolla-Salas J, León C, Palomar M, Jordá R, Carrasco N, Bobillo F, EPCAN Study Group . 2003. Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29:1069–1076. doi:10.1007/s00134-003-1807-y - DOI - PubMed

Publication types